Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the australian rheumatology association database

HIGHLIGHTS

• who: John Oldroyd and collaborators from the Department of Clinical Epidemiology, Cabrini Institute, Wattletree Road, Malvern, VIC, Australia University, VIC, Australia have published the Article: Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database, in the Journal: (JOURNAL) of 13/04/2009
• what: The aim of this study was to describe the baseline characteristics including comorbidities of a populationbased cohort of Australian patients with AS participating in ARAD who are commencing bDMARDs and to compare them to the baseline characteristics of participants enrolled in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.